ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,363.02
1.11%
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs Yen
161.041
0.08%
Brent Oil
85.385
0.32%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/0114 : 59Business WireAccenture Completes Acquisition of OPENSTREAM HOLDINGSNYSE:ACNAccenture Plc
2024/07/0114 : 58PR Newswire (US)Monster Energy Riders Sweep Podium in BMX Street with Kevin Peraza Taking Gold, Jordan Godwin Silver, and Lewis Mills Bronze and Tom Schaar Takes Gold in Skateboard Vert
2024/07/0114 : 55GlobeNewswire Inc.Share repurchase programmeTG:JYS1Jyske Bank AS
2024/07/0114 : 55GlobeNewswire Inc.Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next WeekNASDAQ:MESOMesoblast Limited
2024/07/0114 : 55GlobeNewswire Inc.Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next WeekMSB.AX
2024/07/0114 : 53Alliance NewsAlliance NewsUS bases in Europe on high alert amid possible terror threat
2024/07/0114 : 50Alliance NewsAlliance NewsAirbus says will buy "major activities" of subcontractor Spirit
2024/07/0114 : 49Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 called up on week of UK election
2024/07/0114 : 49Business WireMOGAS signe un contrat pour soutenir la nouvelle technologie TC2C™
2024/07/0114 : 49Business Wireモガス、TC2C™新技術のサポート契約を獲得
2024/07/0114 : 49Business WireMOGAS erhält Auftrag zur Unterstützung der neuen TC2C™-Technologie
2024/07/0114 : 45GlobeNewswire Inc.Wendel joins Providence to support Globeducate, a leading international K-12 education group, through its next phase of growthTG:WISWendel SA
2024/07/0114 : 45GlobeNewswire Inc.Wendel et Providence accompagneront conjointement Globeducate, un groupe d’écoles internationales de la maternelle au secondaire, dans sa prochaine phase de croissanceEU:MFWendel SA
2024/07/0114 : 45GlobeNewswire Inc.Wendel joins Providence to support Globeducate, a leading international K-12 education group, through its next phase of growthEU:MFWendel SA
2024/07/0114 : 45GlobeNewswire Inc.Wendel et Providence accompagneront conjointement Globeducate, un groupe d’écoles internationales de la maternelle au secondaire, dans sa prochaine phase de croissanceTG:WISWendel SA
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKTG:9RSSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKEU:SWPSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneEU:SWPSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneLSE:0MN5Sword Group Se
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneTG:9RSSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKLSE:0MN5Sword Group Se
2024/07/0114 : 38Alliance NewsAlliance NewsIrish slowdown in manufacturing accelerates in June; outlook positive
2024/07/0114 : 33PR Newswire (US)Global Times: CPC members reach 99.185 million
2024/07/0114 : 31GlobeNewswire Inc.Kalmar’s financial information in 2024
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:INHCInduction Healthcare Group Plc
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:PRVPorvair Plc
2024/07/0114 : 30Alliance NewsAlliance NewsAlliance News UK - start of day
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ LSE:0RADOse Immunotherapeutics Sa
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics

最近閲覧した銘柄

NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
FX
USDGBP
US Dollar vs Sterling
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
FX
USDEUR
US Dollar vs Euro
USOTC
BNPQY
BNP Paribas (QX)
NYSE
AXP
American Express
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有